Dolutegravir Impurity D
- CAS2374716-73-9
- CatalogueRS-D057025
- FormulaC20H19F2N3O5
- MW419.38
On this page
Custom synthesis — structure on request
Product identification
| Product name | Dolutegravir Impurity D |
|---|---|
| Catalogue No. | RS-D057025 |
| CAS No. | 2374716-73-9 |
| Molecular formula | C20H19F2N3O5 |
| Molecular weight | 419.38 |
| Exact mass | 419.1293 (monoisotopic) |
| Availability | Back order— restocking can be arranged, about 1–2 weeks |
| Standard type | Impurity Reference Standards |
| Drug substance | Dolutegravir |
| Also known as | N-(2,4-Difluorobenzyl)-9-hydroxy-2-(4-hydroxybutan-2-yl)-1,8-dioxo-1,8-dihydro-2H-pyrido[1,2-a]pyrazine-7-carboxamide; Dolutegravir Sodium Impurity 42 |
| Storage | Refer to the certificate of analysis (COA) supplied with each lot |
| Intended use | For laboratory and research use only. Not for human or veterinary use. |
What is stated on the certificate
Content and purity are assigned per lot and stated on the certificate of analysis issued for the batch you receive — they are not a catalogue-level figure. The certificate records the tests performed, the specification applied and the result obtained for that lot.
| Field | Basis |
|---|---|
| Identity | Spectroscopic and chromatographic methods appropriate to the material |
| Purity | Chromatographic purity, area normalisation unless stated otherwise |
| Assay / content | Mass balance, corrected for the stated volatiles and residue |
| Catalogue and batch numbers | RS-D057025 / batch number on the certificate |
| Retest date | Printed on the certificate for the lot supplied |
Frequently asked
What documentation is supplied with this lot?
Is the assigned value given on an “as is” basis?
How should this material be stored?
Do you supply pack sizes other than those listed?
Finding this standard
Buyers reach this compound by CAS number, by catalogue number, through the drug substance it belongs to, or through the type of standard it is. Those routes all start here:
- Other impurities of Dolutegravir
- Impurity Reference Standards of this kind
- Documents for this item (COA, SDS)
- Certificate of analysis for RS-D057025
- Request a quotation for RS-D057025
Searching another way? Send the structure, a SMILES string or the pharmacopoeial name — a CAS number is not required for a non-compendial impurity. Write to sales@rssechem.com.
Other standards of Dolutegravir
All 55 further standards are on this page — 20 shown at first, then 20 more per click on Load more.
Dolutegravir
IN STOCKRS-Z393L2G(R)-3-Aminobutanoic acid hydrochloride
CUSTOM SYNTHESISRS-U080819(R)-N-(4-hydroxybutan-2-yl)acetamide
IN STOCKRS-C031011(S)-N-(4-hydroxybutan-2-yl)acetamide
CUSTOM SYNTHESISRS-U070196(Z)-Methyl2-[(Dimethylamino)methylene]-4-methoxy-3-oxobutanoate
CUSTOM SYNTHESISRS-Z396SB91-(2,3-Dihydroxypropyl)-4-oxo-3-[(phenylmethyl)oxy]-1,4-dihydro-2-pyridinecarboxylic Acid
CUSTOM SYNTHESISRS-Z001P9C2-[(1E)-2-Phenylethenyl]-3-(phenylmethoxy)-4H-pyran-4-one
IN STOCKRS-Z001P9B3-Benzyloxy-2-(2-hydroxy-2-phenylethyl)-4H-pyran-4-one
IN STOCKRS-Z395J2M4-Oxo-4H-pyran-2,5-dicarboxylic Acid 2,5-Diethyl Ester
IN STOCKRS-O601001Dolutegravir USP Related Compound A
IN STOCKRS-D057013Dimethyl 2-((dimethylamino)methylene)malonate
IN STOCKRS-P006856Dolutegravir D3
BACK ORDERRS-Z413D8SDolutegravir Diastereomer Sodium
IN STOCKRS-I097399Dolutegravir Enantiomer
IN STOCKRS-I010025Dolutegravir ethyl ester impuirty
IN STOCKRS-D057033Dolutegravir Metabolite CYP3A4 (M3)
CUSTOM SYNTHESISRS-D057030Dolutegravir Open Ring Impurity
IN STOCKRS-D057006Dolutegravir RR Isomer
IN STOCKRS-I010031Dolutegravir Sodium Salt
IN STOCKRS-U004113Dolutegravir SS Isomer
BACK ORDERRS-I010032Dolutegravir(methyl-d3,N-methyl-d2)-d6
CUSTOM SYNTHESISRS-D057015Dolutegravir-D4
BACK ORDERRS-D057086Dolutegravir-d5
BACK ORDERRS-D057032Dolutegravir Impurity 1
CUSTOM SYNTHESISRS-D057012Dolutegravir Impurity 3
BACK ORDERRS-D057011Dolutegravir Impurity 4
BACK ORDERRS-D057026Dolutegravir Impurity 8
IN STOCKRS-D057004Dolutegravir Impurity 14
IN STOCKRS-D057009Dolutegravir Impurity 15
IN STOCKRS-D057010Dolutegravir Impurity 16
CUSTOM SYNTHESISRS-D057028Dolutegravir Impurity 19
BACK ORDERRS-D057168Dolutegravir Impurity 21
BACK ORDERRS-I001A9NDolutegravir Impurity 25
IN STOCKRS-D057001Dolutegravir Impurity 28
BACK ORDERRS-D057020Dolutegravir Impurity 32
IN STOCKRS-D057003Dolutegravir Impurity 39
CUSTOM SYNTHESISRS-D057021Dolutegravir Impurity 46
IN STOCKRS-Z401FJVDolutegravir Impurity 50
IN STOCKRS-I001AGODolutegravir Impurity 60
IN STOCKRS-I001AQGDolutegravir Impurity 107
BACK ORDERRS-D057029Dolutegravir Impurity 121
BACK ORDERRS-D057031Dolutegravir Impurity 123
IN STOCKRS-D057002Dolutegravir Impurity 125
IN STOCKRS-D057027Dolutegravir Impurity 127
IN STOCKRS-D057005Dolutegravir Impurity 128
IN STOCKRS-D057007Dolutegravir Impurity 129
IN STOCKRS-D057008Dolutegravir Impurity 130
IN STOCKRS-D057014Dolutegravir Impurity 131
IN STOCKRS-D057017Dolutegravir Impurity 132
CUSTOM SYNTHESISRS-D057018Dolutegravir Impurity 133
BACK ORDERRS-D057019Dolutegravir Impurity 134
BACK ORDERRS-D057023Dolutegravir Impurity 135
IN STOCKRS-D057024
Pharmacopoeial names (EP, USP, BP, JP) are used for identification purposes only and do not imply endorsement by those bodies. This product is supplied for laboratory and research use only — not for human or veterinary use.




![Chemical structure of (Z)-Methyl2-[(Dimethylamino)methylene]-4-methoxy-3-oxobutanoate](/structures/w4/YOMXMNVCBBDQDO-ALCCZGGFSA-N.webp?v=11)
![Chemical structure of 1-(2,3-Dihydroxypropyl)-4-oxo-3-[(phenylmethyl)oxy]-1,4-dihydro-2-pyridinecarboxylic Acid](/structures/w4/RTNJSNISZQOUJS-UHFFFAOYSA-N.webp?v=11)
![Chemical structure of 1-(2,3-Dihydroxypropyl)-4-oxo-3-[(phenylmethyl)oxy]-1,4-dihydro-2-pyridinecarboxylic Acid Methyl Ester](/structures/w4/JUVSRACZYLMJQD-UHFFFAOYSA-N.webp?v=11)
![Chemical structure of 2-[(1E)-2-Phenylethenyl]-3-(phenylmethoxy)-4H-pyran-4-one](/structures/w4/GRNZXGRTBJGQGT-UHFFFAOYSA-N.webp?v=11)













































